Zantac To Be Recalled in U.S. and Canada on Carcinogen Concern
The company logo sits on display outside the headquarters of pharmaceutical company Sanofi in Paris, France (Photographer: Balint Porneczi/Bloomberg)  

Zantac To Be Recalled in U.S. and Canada on Carcinogen Concern

Bookmark
(Bloomberg) -- Sanofi is voluntarily recalling heartburn medication Zantac in the U.S. and Canada amid worries that the medicine may be tainted with a compound that could cause cancer.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.